Clinical Trial Update: A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating mosunetuzumab alone or in combination with zanubrutinib in people with follicular lymphoma and other lymphomas, and the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Lymphoma

Drugs mentioned

• BRUKINSA (ZANUBRUTINIB)
• LUNSUMIO (mosunetuzumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Follicular Lymphoma, Lymphoma | Phase 2 | Status: RECRUITING